Filing Details
- Accession Number:
- 0001638599-17-000690
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-07-10 16:19:30
- Reporting Period:
- 2017-06-15
- Filing Date:
- 2017-07-10
- Accepted Time:
- 2017-07-10 16:19:30
- Original Submission Date:
- 2017-06-19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1453687 | Selecta Biosciences Inc | SELB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1676905 | P. Lloyd Johnston | C/O Selecta Biosciences, Inc. 480 Arsenal Way Watertown MA 02472 | Coo And Svp, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-15 | 10,512 | $0.47 | 12,118 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-15 | 10,512 | $17.04 | 1,606 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-06-15 | 10,512 | $0.00 | 10,512 | $0.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,000 | 2019-07-23 | No | 4 | M | Direct |
Footnotes
- On June 19, 2017, the reporting person filed a Form 4 reporting the June 15, 2017 exercise and sale of 20,512 shares of common stock pursuant to a 10b5-1 plan. The reporting person's broker subsequently acknowledged that 10,000 of such 20,512 shares were erroneously exercised and sold by the broker. The exercise and sale of the 10,000 shares was unwound through the broker's error account and therefore did not occur for purposes of the reporting person's account. This Form 4 amends and restates, in their entirety, the transactions reported in the June 19, 2017 Form 4.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.96 to $17.10, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- All shares underlying this option are fully vested.
Billionaire Hedge Funds
